10/06/2025
🌿 Understanding Amvuttra & Amyloidosis 🌿
Amyloidosis is a rare condition that happens when abnormal proteins build up in your organs and tissues — but new treatments are offering hope. 💙
Amvuttra (vutrisiran) is a breakthrough medication designed to reduce these harmful proteins, helping patients with both:
🧠 hATTR Polyneuropathy (nerve-related)
❤️ ATTR-CM (heart-related)
Given as a small injection every 3 months, Amvuttra can help slow disease progression, improve daily function, and enhance quality of life.
At Sage Infusion, we administer innovative therapies like Amvuttra in a supportive, patient-centered environment because understanding your treatment is the first step toward feeling better.
👉 Learn more about Amyloidosis and Amvuttra in our latest Health Blog: https://sageinfusion.com/2025/10/01/understanding-amvuttra-and-amyloidosis/
Amyloidosis is a rare condition that can feel overwhelming—especially with names like “hereditary transthyretin-mediated amyloidosis” and “ATTR-cardiomyopathy.” But let’s break it down simply, so you can understand what’s happening in your body and how Amvuttra may help.